$174 Million is the total value of Birchview Capital, LP's 48 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 16.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $49,276,000 | -48.6% | 794,386 | -50.0% | 28.39% | -11.3% |
| BDSX | New | BIODESIX INC | $22,278,000 | – | 1,105,083 | +100.0% | 12.84% | – |
| AXDX | Sell | ACCELERATE DIAGNOSTICS INC | $16,629,000 | -64.4% | 2,193,795 | -50.0% | 9.58% | -38.7% |
| QDEL | Sell | QUIDEL CORP | $10,535,000 | -59.1% | 58,644 | -50.0% | 6.07% | -29.4% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $7,687,000 | -48.8% | 80,200 | -48.6% | 4.43% | -11.6% |
| FHTX | New | FOGHORN THERAPEUTICS INC | $6,368,000 | – | 314,143 | +100.0% | 3.67% | – |
| AWH | Sell | ASPIRA WOMENS HEALTH INC | $5,620,000 | -70.5% | 840,104 | -86.4% | 3.24% | -49.1% |
| ACAD | Sell | ACADIA PHARMACEUTICALS INC | $5,453,000 | -35.2% | 102,000 | -50.0% | 3.14% | +11.8% |
| ALBO | Sell | ALBIREO PHARMA INC | $3,451,000 | -10.8% | 92,000 | -20.7% | 1.99% | +53.8% |
| OXFD | Sell | OXFORD IMMUNOTEC GLOBAL PLC | $2,974,000 | -25.4% | 170,303 | -50.0% | 1.71% | +28.6% |
| BIIB | Sell | BIOGEN INC | $2,963,000 | -52.5% | 12,100 | -45.0% | 1.71% | -18.1% |
| KPTI | Sell | KARYOPHARM THERAPEUTICS INC | $2,910,000 | -40.7% | 188,000 | -44.0% | 1.68% | +2.3% |
| UTHR | Sell | UNITED THERAPEUTICS CORP | $2,732,000 | -24.9% | 18,000 | -50.0% | 1.57% | +29.5% |
| BLUE | Sell | BLUEBIRD BIO INC | $2,683,000 | -58.6% | 62,000 | -48.3% | 1.55% | -28.5% |
| XLRN | Sell | ACCELERON PHARMA INC | $2,389,000 | -43.1% | 18,672 | -50.0% | 1.38% | -2.0% |
| MASI | Sell | MASIMO CORP | $2,147,000 | -43.1% | 8,000 | -50.0% | 1.24% | -1.9% |
| CCXI | Sell | CHEMOCENTRYX INC | $1,858,000 | -43.5% | 30,000 | -50.0% | 1.07% | -2.6% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $1,690,000 | -48.6% | 22,000 | -50.0% | 0.97% | -11.4% |
| SLNO | Sell | SOLENO THERAPEUTICS INC | $1,596,000 | -61.6% | 826,899 | -50.0% | 0.92% | -33.7% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $1,467,000 | -41.9% | 300,000 | -50.0% | 0.84% | +0.1% |
| PROG | New | PROGENITY INC | $1,328,000 | – | 250,000 | +100.0% | 0.76% | – |
| CORT | Sell | CORCEPT THERAPEUTICS INC | $1,308,000 | -24.8% | 50,000 | -50.0% | 0.75% | +29.8% |
| ARVN | Sell | ARVINAS INC | $1,274,000 | +79.9% | 15,000 | -50.0% | 0.73% | +209.7% |
| STOK | Sell | STOKE THERAPEUTICS INC | $1,239,000 | -7.5% | 20,000 | -50.0% | 0.71% | +59.4% |
| HROW | Sell | HARROW HEALTH INC | $1,235,000 | -38.6% | 180,000 | -50.0% | 0.71% | +5.8% |
| IMGN | Sell | IMMUNOGEN INC | $1,226,000 | -10.4% | 190,000 | -50.0% | 0.71% | +54.5% |
| ETRN | Sell | EQUITRANS MIDSTREAM CORPORATIO | $1,070,000 | -52.5% | 133,050 | -50.0% | 0.62% | -18.1% |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $1,051,000 | -32.0% | 80,000 | -50.0% | 0.60% | +17.2% |
| CFRX | Sell | CONTRAFECT CORP | $1,010,000 | -62.6% | 200,000 | -60.9% | 0.58% | -35.5% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $877,000 | -18.3% | 38,000 | -50.0% | 0.50% | +40.7% |
| BHVN | Sell | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | $857,000 | -34.1% | 10,000 | -50.0% | 0.49% | +13.8% |
| TGTX | Sell | TG THERAPEUTICS INC | $780,000 | -2.7% | 15,000 | -50.0% | 0.45% | +67.5% |
| BMYRT | Sell | BMY CVR RTS 03/31/21right | $763,000 | -85.9% | 1,105,313 | -42.3% | 0.44% | -75.7% |
| GTHX | Sell | G1 THERAPEUTICS INC | $720,000 | -22.1% | 40,000 | -50.0% | 0.42% | +34.3% |
| PGNY | Sell | PROGYNY INC | $636,000 | -27.9% | 15,000 | -50.0% | 0.37% | +24.1% |
| CLR | Sell | CONTINENTAL RESOURCES INC | $629,000 | -33.6% | 38,600 | -50.0% | 0.36% | +14.2% |
| NARI | Sell | INARI MEDICAL INC | $611,000 | -36.7% | 7,000 | -50.0% | 0.35% | +9.0% |
| KALV | Sell | KALVISTA PHARMACEUTICALS INC | $570,000 | -24.6% | 30,000 | -50.0% | 0.33% | +29.6% |
| TBIO | Sell | TRANSLATE BIO INC | $553,000 | -32.2% | 30,000 | -50.0% | 0.32% | +16.8% |
| XNCR | Sell | XENCOR INC | $537,000 | -43.7% | 12,300 | -50.0% | 0.31% | -3.1% |
| OVV | Sell | OVINTIV INC | $493,000 | -12.0% | 34,350 | -50.0% | 0.28% | +51.9% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $458,000 | -5.0% | 8,000 | -50.0% | 0.26% | +64.0% |
| PXD | Sell | PIONEER NATURAL RESOURCES CO | $433,000 | -33.8% | 3,800 | -50.0% | 0.25% | +14.2% |
| ODT | Sell | ODONATE THERAPEUTICS INC | $384,000 | -28.6% | 20,000 | -50.0% | 0.22% | +22.8% |
| IFRX | Sell | INFLARX NV | $352,000 | -40.9% | 70,000 | -50.0% | 0.20% | +2.0% |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $220,000 | -38.9% | 10,000 | -50.0% | 0.13% | +5.8% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $149,000 | +8.0% | 20,000 | -50.0% | 0.09% | +87.0% |
| YTEN | Sell | YIELD10 BIOSCIENCE INC | $110,000 | -62.6% | 18,952 | -50.0% | 0.06% | -35.7% |
| WKHS | Exit | WORKHORSE GROUP INC | $0 | – | -16,000 | -100.0% | -0.14% | – |
| VYGR | Exit | VOYAGER THERAPEUTICS INC | $0 | – | -60,000 | -100.0% | -0.21% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS INC | $0 | – | -16,600 | -100.0% | -0.23% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -140,000 | -100.0% | -0.56% | – |
| MYOK | Exit | MYOKARDIA INC | $0 | – | -20,000 | -100.0% | -0.91% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACCELERATE DIAGNOSTICS INC | 36 | Q3 2023 | 34.6% |
| QUIDELORTHO CORP | 36 | Q3 2023 | 8.6% |
| MASIMO CORP | 36 | Q3 2023 | 2.2% |
| PIONEER NATURAL RESOURCES CO (PXD) | 36 | Q3 2023 | 0.7% |
| XENCOR INC | 35 | Q3 2023 | 0.4% |
| NEUROCRINE BIOSCIENCES INC | 33 | Q3 2023 | 7.4% |
| CORCEPT THERAPEUTICS INC | 32 | Q3 2023 | 1.2% |
| BIOGEN INC | 31 | Q2 2022 | 3.1% |
| CONTRAFECT CORP | 30 | Q3 2022 | 1.6% |
| YIELD10 BIOSCIENCE INC | 26 | Q3 2023 | 0.6% |
View Birchview Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SOLENO THERAPEUTICS INC | March 19, 2019 | 742,635 | 2.3% |
| YIELD10 BIOSCIENCE, INC. | December 29, 2017 | 186,079 | 2.2% |
| HANSEN MEDICAL INC | February 16, 2016 | ? | ? |
| METABOLIX, INC. | June 23, 2015 | 749,696 | 2.8% |
View Birchview Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3/A | 2024-02-20 |
| 4/A | 2024-02-20 |
| SC 13G/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-04-07 |
| 4 | 2023-03-27 |
| 3 | 2023-02-13 |
View Birchview Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.